Sionna Therapeutics, Inc.

US$3.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SIONHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (32.34%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (91.42%)
Mkt cap US$148.3M
ROIC (22.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.76
14.50%
(77.91%)
Hold 8|12|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
15.88%
10.36%
8.93%
0.68%
Revenue$M
8.934
8.728
8.639
8.602
6.28%
(1.26%)
0.26%
(0.39%)
Peers (US$148.3M)
Cap (US$)
PE
148.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.655
(0.076)
(0.092)
EBIT/Intx
2.711
0.207
0.187
Own earn%
16.31
54.28
53.88
Sh yield%
42.46
45.90
42.96
Owners
Insiders/Inst%
4.21
59.13
Short interest%
5.56
SBC / revenue%
2.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
2–14
$1 testx
—
Incr. ROIC%
3